Literature DB >> 8645374

CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese.

M Kinoshita1, T Teramoto, N Shimazu, K Kaneko, M Ohta, T Koike, S Hosogaya, Y Ozaki, S Kume, M Yamanaka.   

Abstract

Cholesteryl ester transfer protein (CETP) is one of the factors that regulate plasma levels of HDL-cholesterol. To identify the factors that may regulate CETP activity, and to determine to what extent CETP is correlated with physiologic concentrations of lipoprotein, we performed an epidemiologic study in 586 healthy volunteers (317 males and 269 females mean age 52.2 +/- 10.9 years). CETP activity in these subjects was 192.96 +/- 48.73 (mean +/- S.D.) nmol/ml/h and distributed to a wide range (60-450 nmol/ml/h). Using multiple regression analysis, we found significant positive correlations between CETP activity and LDL-cholesterol (P < 0.03), apolipoprotein (apo) E (P < 0.005) and LCAT activity (P < 0.001). CETP activities showed significant negative correlation with apo A-I (P < 0.03). However, CETP activity showed no significant correlation either with HDL cholesterol or with apo B. One-way layout analysis of variance showed that alcohol drinking and cigarette smoking significantly reduced CETP activity, but there was no significant association between CETP activity and body mass index. Although CETP activities were significantly higher in females than in males (P < 0.001), multiple regression analysis showed no correlation between CETP activity and age in either the males or the females. Our results suggest that CETP activity regulates the concentration of apo A-I and LDL-cholesterol, and that such activity may be influenced by gender, alcohol consumption and cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645374     DOI: 10.1016/0021-9150(95)05684-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population.

Authors:  Aya Hirata; Tomonori Okamura; Daisuke Sugiyama; Kazuyo Kuwabara; Aya Kadota; Akira Fujiyoshi; Katsuyuki Miura; Nagako Okuda; Takayoshi Ohkubo; Akira Okayama; Hirotsugu Ueshima
Journal:  J Atheroscler Thromb       Date:  2016-02-26       Impact factor: 4.928

2.  Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics.

Authors:  Daniel B Larach; Marina Cuchel; Daniel J Rader
Journal:  Clin Lipidol       Date:  2013-12

3.  Pioglitazone decreases plasma cholesteryl ester transfer protein mass, associated with a decrease in hepatic triglyceride content, in patients with type 2 diabetes.

Authors:  Jacqueline T Jonker; Yanan Wang; Willeke de Haan; Michaela Diamant; Luuk J Rijzewijk; Rutger W van der Meer; Hildo J Lamb; Jouke T Tamsma; Albert de Roos; Johannes A Romijn; Patrick C N Rensen; Johannes W A Smit
Journal:  Diabetes Care       Date:  2010-02-11       Impact factor: 17.152

4.  Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.

Authors:  Ramachandran S Vasan; Michael J Pencina; Sander J Robins; Justin P Zachariah; Guneet Kaur; Ralph B D'Agostino; Jose M Ordovas
Journal:  Circulation       Date:  2009-12-15       Impact factor: 29.690

5.  Moderate alcohol consumption and lipoprotein subfractions: a systematic review of intervention and observational studies.

Authors:  Trine L Wilkens; Kaare Tranæs; Jane N Eriksen; Lars O Dragsted
Journal:  Nutr Rev       Date:  2022-04-08       Impact factor: 6.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.